Exclusive: Pfizer warns EU to back down on vaccine threats to UK. Drugmaker warns Brussels that UK has the power to retaliate against any export ban by withholding raw materials shipped from Yorkshire
Pfizer and its partner BioNTech have warned the EU to back down from its threat to block vaccines to the UK because the firm needs crucial ingredients shipped from Yorkshire, and the UK could retaliate against any export ban by withholding raw materials needed for its jab.
Croda International, a chemicals firm based in Staith, North Yorkshire, has been delivering vital "fatty molecules" to Pfizer's factories in the EU since signing a five-year contract with the firm in November.
Pfizer and BioNtech are understood to have warned EU leaders that production at their main vaccine factory in Belgium could "grind to a halt" within weeks if the UK moved to prevent deliveries from crossing the Channel.
It comes amid a bitter international row over vaccine supplies after Macron backed a threat by the EU Commission president Von der Leyen, to seize factories, waive patents and ban vaccine exports to the UK unless Boris Johnson surrendered British-made AstraZeneca jabs to the EU.
One senior UK Govt source involved in tackling the Covid pandemic played down the chance that Britain would retaliate by blocking its own exports of vaccine components to Europe.
However, Pfizer and BioNtech are understood to have privately warned the commission that any vaccine ban on the UK would risk provoking a Downing Street backlash that could further derail the bloc's stuttering vaccine rollout
The drugmaker has already admitted it faces a global shortage of lipid nanoparticles, the specialised fatty molecules used to encase the fragile mRNA vaccine and safely deliver it to human cells.
A Pfizer spokesman said: "We have been clear with all stakeholders that the free movement of goods and supply across borders is absolutely critical to Pfizer and the patients we serve."
Last November, Pfizer signed a five-year deal with the Yorkshire-based firm Croda International, one of the few companies in the world able to supply the crucial substance. Croda is quadrupling the capacity of its UK factory to meet demand.
The Pfizer/BioNTech recently announced contracts with Germany-based companies to scale up the supply of lipids. However, lipids supply remains the key bottleneck facing the production of the Pfizer vaccine and it would take up to 8 months to boost production.
"We need kilos and kilos and kilos of that stuff," Mr Poetting (the BioNTech chief operating officer) said, adding that any export restrictions could endanger the supply. The Pfizer/BioNTech vaccine is also reliant on components shipped from the US and Canada.
A senior UK government source played down the idea of a retaliatory ban, stressing that Britain seeks to attract new businesses: "... if you want to come and set up your manufacturing base in the UK you can".
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Diplomacy is usually shaped by interests rather than past grudges. As Eurocrats were gradually replaced by successors coming fresh to the job, I expected the EU to concentrate on its own prosperity rather than entering into a series of needless scraps with its largest customer.
I was wrong.
The EU’s rage will last for years, possibly decades, and we need to adjust our foreign policy accordingly. I am not talking here of provocations (Michel’s outrageous claim the UK is blocking vaccines, aggressive tweets, petty diplomatic micro-aggressions ... ).
#UK Bid to make more vaccines in Britain as the EU ramps up its threats.
Ministers are working on plans to accelerate the onshoring of coronavirus vaccine production to make the country more self-sufficient amid fears of rising vaccine nationalism. telegraph.co.uk/politics/2021/…
In some EU countries, there are excess supplies of the AstraZeneca jab, despite the supply issues. Decisions by several EU countries to suspend use of the AstraZeneca vaccine on suspicion that it causes blood clots served to further tarnish its reputation.
On Saturday night responding to the remarks from Mrs Von der Leyen, a UK Govt source said: “It’s incredibly frustrating that there are 7.2 million unused doses of the Oxford vaccine sitting around in the EU. The EU has monumentally ballsed this up.
The Super Heavy Booster, the other half of SpaceX's Starship deep-space transportation system, is starting to come out into the light. space.com/spacex-first-s…
A regime that behaves like the EU is liable to impose capital controls without compunction, or block energy flows through the interconnectors, as threatened 3 times already (I keep count). And as we have seen, anything can be politicised, even random stochastic blood clots.
We want to see reciprocity and proportionality in exports,” said Mrs Von der Leyen. Delicious. The EU is currently refusing to reciprocate temporary UK waivers to smooth post-Brexit trade flows or to reciprocate on bare-bond equivalence in financial services.
The UK's vaccination efforts will be paralysed from next month because the Indian Government is temporarily holding exports, according to the CEO of the Serum Institute of India (SII), Adar Poonawalla, whose company is manufacturing the AstraZeneca vaccine in India.
"It has nothing to do with the SII. It is up to the Indian Government allowing more doses to the UK," Mr Poonawalla told The Telegraph, who confirmed that 5 million doses of the Oxford vaccine had already been delivered to the UK in early March.
The second batch of 5 million further doses that the SII has pledged to the UK will only be delivered once the company was given the green light by New Delhi, which is deliberating how to slow a concerning resurgence in new daily Covid-19 cases, according to a source.
Data show the UK did not suffer a bigger contraction than the €Z in 2020 (confusion due to different GDP measurement models: a like-for-like was -4,8% instead of -10%) and is better placed to bounce back to pre-pandemic GDP levels in 2021.
By AEP telegraph.co.uk/business/2021/…
The UK economy did not suffer a bigger contraction than the eurozone last year. The narrative, believed by the London media,
never made sense. We now have the data, and we can see more clearly that it never happened. It was a story of apples and oranges.
Confusion over past data is due to measurement models. The ONS deducts a fall in visits to the doctor and reduced classes at school from accrued GDP. Most other countries do not. They calculate extra health spending as a boost to GDP. Hence a giant anomaly.